Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Development of New Antibiotics Against Multidrug-Resistant Staphylococcus aureus
PKC Delta as a Tumor Suppressor for Human Skin Cancer
Ion Transport in Collecting Cell Cultures
Hepatocytes - Transplantation, Extracorporeal Support
Methods for Assessment of Environmental Hazards
Recently added grants:
Understanding the reciprocal regulation between Hsp70 and the DNA damage response
Novel strategies to understand, predict, and prevent vascular toxicity of targeted CML therapies
Generalizable prediction of medication adherence in heart failure
Identifying mechanisms and reversibility of eosinophil-induced airway hyperinnervation in asthma
Mesenchymal modulation of epithelial metaplasia in lung fibrosis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67186-2-0-1
Application #
7574878
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ Children's Hospital & Res Ctr at Oakland
$366,202
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Morris, Claudia /
$359,807
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
Comments
Be the first to comment on this grant